Karen Brophy

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

Agilex Flavors & Fragrances, Inc. manufactures and supplies flavor and fragrance ingredients. It products include oil-based and water-based fragrance gel matrixes, air freshener gel matrixes, air freshener delivery systems, home fragrances, thermoplastic air freshener matrixes, fragrance polymer concentrates, foamed fragrance polymer beads, thixotropic sprays and fragrance additives. The company was founded in 1999 and is headquartered in Piscataway, NJ.